Paragon Healthcare
Paragon Healthcare is a Dallas-based specialty infusion services provider delivering injectable and infusible drug therapies across 40+ U.S. locations through home infusion, outpatient infusion centers, and specialty pharmacy, serving 35,000+ patients annually with chronic and rare conditions including hemophilia and IVIG-therapy indications.
- Company typePrivate
- Founded2002
- HeadquartersDallas, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Paragon Healthcare does
Paragon Healthcare, founded in 2002 and headquartered in Dallas, Texas, is a specialty infusion services provider that delivers injectable and infusible drug therapies through three integrated channels: in-home infusion, a network of company-operated outpatient infusion centers, and specialty pharmacy dispensing. The company treats more than 300 chronic and acute conditions across neurology, rheumatology, gastroenterology, immunology, dermatology, hematology, and hepatology, with particular depth in hemophilia and other bleeding disorders, IVIG/SCIG therapy for primary immunodeficiency and autoimmune disease, and rare disease care. As of 2024, Paragon served over 35,000 patients annually, employed more than 1,000 staff, and operated 40+ infusion center and pharmacy locations across 10+ U.S. states, with a publicly stated plan to add 50+ additional locations over the following five years.
The underlying technology platform combines electronic health information systems, telehealth-enabled patient education for self-administration of infusion pumps and drug therapy, and a national overnight shipping logistics operation that delivers ready-to-use medications and supplies directly to patients. The company operates four core product lines — Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, and Paragon Specialty Pharmacy — plus an in-office infusion suite offering for physician practices. Paragon holds dual URAC and ACHC accreditations and is HIPAA-compliant, with URAC specialty pharmacy accreditation valid through December 1, 2027. The organization maintains 11 disclosed wholly-owned subsidiaries supporting capabilities such as hemophilia solutions, infusion care, nutrition care, reimbursement, and regional pharmacy operations.
Paragon generates revenue through insurance billing for specialty medications, infusion administration, and care-coordination services (including prior authorizations and benefits verification), supplemented by patient financial assistance programs connected through NeedyMeds and manufacturer programs. Its go-to-market is physician-led referral combined with direct patient outreach, supported by a clinical team of pharmacists, registered nurses, and patient care representatives. Founder-led for two decades, the company received a private-equity investment from Peak Rock Capital in 2020, transitioned to new CEO Anthony Mollica in 2021, and was acquired by Elevance Health in 2024, where it now operates as part of the Carelon health services platform.
Paragon Healthcare firmographics
Firmographics- Name
- Paragon Healthcare
- Legal name
- Paragon Healthcare, Inc.
- Website
- https://paragonhealthcare.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Paragon Healthcare is a Dallas-based specialty infusion services provider delivering injectable and infusible drug therapies across 40+ U.S. locations through home infusion, outpatient infusion centers, and specialty pharmacy, serving 35,000+ patients annually with chronic and rare conditions including hemophilia and IVIG-therapy indications.
- Ownership category
- akta.pro rank
Paragon Healthcare industry classification
Industry- Product category
- Specialty Infusion Therapy Services
- NAICS
- All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Home Infusion Therapy Providers (HLAFAEAE), Infusion Therapy Centers (Outpatient) (HLAFABAF), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)
Keywords
Where Paragon Healthcare is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices49 records
Markets served
Paragon Healthcare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Specialty Pharmacy and Infusion Services: Revenue is generated through the provision of specialty injectable and infusible drug therapies, administered either in the patient's home, at one of Paragon's infusion centers, or through specialty pharmacy dispensing. The company handles billing for medications, infusion services, and related care coordination services including prior authorizations and reimbursement management. As of 2018, the company reported approximately $275 million in annual revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Patient Financial Assistance Program |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Paragon Healthcare product offering
Product offeringCore offering
Paragon Healthcare provides specialty infusion therapy services through an integrated model spanning outpatient infusion centers, home-based infusion delivery with overnight medication shipping, and specialty pharmacy dispensing. The company administers injectable and infusible drug therapies for 300+ chronic and acute conditions including hemophilia, primary immunodeficiency, autoimmune disorders, and other rare diseases. Service lines include Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, Paragon Specialty Pharmacy, and IVIG therapy, all supported by insurance verification, prior authorization, 24/7 pharmacist support, and coordination with referring physicians.
Product overview
Paragon Healthcare operates as a specialty infusion services provider with a portfolio of four integrated core service lines: Paragon Infusion Centers (outpatient clinical settings), Paragon Home Infusion (home-based therapy), Paragon Hemophilia (specialized bleeding disorder division), and Paragon Specialty Pharmacy. These services are unified by shared clinical capabilities in injectable and infusible drug therapies, 24/7 pharmacist availability, overnight medication shipping, insurance verification support, and coordination with referring physicians. The company treats over 300 conditions including rare diseases, bleeding disorders, immune deficiencies, and chronic inflammatory conditions across dermatology, gastroenterology, rheumatology, neurology, and other specialties. All divisions operate under dual accreditation from URAC and ACHC.
Differentiator
Problem solved
Functional benefit
Products and services
- Paragon Infusion Centers Outpatient infusion centers providing injectable and infusible drug therapies in a controlled clinical setting under the care of registered nurses and nurse practitioners, treating 300+ conditions across multiple specialties.
- Paragon Home Infusion Home-based infusion therapy allowing patients to receive injectable and infusible medications at home, at work, or on-the-go, with overnight shipping of medications and supplies, home health services arrangement, and telehealth-based self-administration training.
- Paragon Hemophilia Specialized division providing customized care plans, factor replacement therapies, and support services for patients with bleeding disorders including Hemophilia A, Hemophilia B, and von Willebrand Disease.
- Paragon Specialty Pharmacy Specialty pharmacy providing injectable and infusible medications for conditions across dermatology, gastroenterology, immunology, hepatology, rheumatology, neurology, urology, and other therapeutic specialties.
- IVIG Therapy Intravenous and subcutaneous immunoglobulin therapy for patients with primary immunodeficiency diseases and autoimmune disorders, available at infusion centers, home infusion, or medical suite settings.
Quantifiable outcome
- Paragon serves 35,000+ patients annually and projects to treat 100,000+ patients annually by 2025
Companies that use Paragon Healthcare
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Paragon Healthcare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Paragon Healthcare partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor.
- Provident Healthcare PartnersminorProvident Healthcare Partners released a Fall 2024 overview of the infusion services sector, highlighting Paragon Healthcare's sale as a significant transaction in the private equity-backed infusion services market.
- National Infusion Center Association (NICA)minorParagon Healthcare, Inc. supports the National Infusion Center Association (NICA), a 501(c)(3) nonprofit organization focused on improving patient access to intravenous and injectable medications.
- National Multiple Sclerosis SocietyminorParagon Healthcare supports the National Multiple Sclerosis Society, which helps people affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, and providing services that help people with MS and their families.
- Hope for HemophiliaminorHope for Hemophilia is a 501(c)(3) nonprofit helping people living with hemophilia and their families through seasons of crisis since 2009 with financial, emotional, and practical support. Paragon directs patients to this resource.
- Hemophilia Federation of AmericaminorHemophilia Federation of America is a patient education, services and advocacy organization for the rare bleeding disorders community, focused on bleeding disorder patients and caregivers. Paragon directs patients to this resource.
- The Coalition for Hemophilia BminorThe Coalition for Hemophilia B strives to make quality of life the focal point of treatment for individuals living with Hemophilia B, pursuing its mission through a family-oriented approach for over 28 years. Paragon directs patients to this resource.
- National Hemophilia FoundationminorThe National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding disorders and preventing complications through education, advocacy, and research. Paragon directs patients to this resource.
- NeedyMedsminorParagon Healthcare connects eligible patients with financial assistance programs through NeedyMeds, a 501(c)(3) nonprofit information resource devoted to helping people in need find assistance programs for their medications and healthcare.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Paragon Healthcare competitors and assessment
Company assessmentDirect peers
- Option Care Health: Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S., operating a national footprint with home infusion, specialty pharmacy, and clinical management across complex therapies. It is the most direct competitor to Paragon's home infusion, specialty pharmacy, and infusion center model.
- Pentec Health: Pentec Health provides specialty infusion, including intrathecal and parenteral therapies, with a clinical and pharmacy focus on complex patients. It overlaps with Paragon's specialty pharmacy and home infusion capabilities for complex injectable and infusible regimens.
- Soleo Health: Soleo Health is a national specialty infusion provider offering home and alternate-site infusion services, specialty pharmacy, and clinical management for complex conditions. It is a directly comparable mid-market peer to Paragon with overlapping therapeutic areas and referral-based GTM.
- BioMatrix Specialty Pharmacy: BioMatrix is a specialty pharmacy focused on infused and injectable therapies for chronic conditions including hemophilia, IVIG, and rare diseases. It mirrors Paragon's specialty pharmacy + infusion service model and serves many of the same physician specialties and therapeutic categories.
- IVX Health: IVX Health operates a national network of outpatient infusion centers focused on biologic infusions for conditions such as rheumatoid arthritis, Crohn's disease, and multiple sclerosis. It directly competes with Paragon Infusion Centers in the outpatient site-of-care category and targets many of the same physician referrals.
- Vivo Infusion: Vivo Infusion is an outpatient infusion center operator offering IV therapy for chronic conditions in a clinic setting. It competes with Paragon Infusion Centers for physician referrals and patient volume in overlapping geographies and therapeutic areas.
- Amerita: Amerita is a specialty infusion provider offering home and alternate-site infusion, including IVIG, TPN, and anti-infective therapies. It is a directly comparable peer in home and specialty infusion with a similar referral-driven, accredited business model.
Broad incumbents
- Accredo (Express Scripts / Evernorth): Accredo is the specialty pharmacy arm of Evernorth/Express Scripts and a leading distributor of specialty injectable and infusible drugs, including hemophilia and IVIG. It competes with Paragon Specialty Pharmacy for payer contracts and manufacturer limited distribution networks at much larger scale.
- Coram CVS Health (Coram): Coram, the infusion services business of CVS Health, provides home infusion and tube feeding nationally as part of CVS's broader pharmacy and care delivery portfolio. It competes head-to-head with Paragon's home infusion offering but benefits from CVS's payer and retail pharmacy scale.
- Walgreens Specialty Pharmacy (including Option Care legacy): Walgreens Specialty Pharmacy, including its specialty infusion and limited distribution drug network, is a broad incumbent competitor in specialty injectable and infusible therapy delivery. It competes with Paragon for payer contracts, manufacturer partnerships, and patient referrals across multiple therapeutic areas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Paragon Healthcare social profiles
Digital presenceParagon Healthcare compliance and trust
Trust signalCompliance3 records
Paragon Healthcare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Paragon Healthcare leadership team
Management profileNumber of profiles
Profiles4 records
Paragon Healthcare subsidiaries and ownership
Company hierarchySubsidiaries11 records
Paragon Healthcare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Paragon Healthcare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Paragon Healthcare
What does Paragon Healthcare do?
Paragon Healthcare provides specialty infusion therapy services through an integrated model spanning outpatient infusion centers, home-based infusion delivery with overnight medication shipping, and specialty pharmacy dispensing. The company administers injectable and infusible drug therapies for 300+ chronic and acute conditions including hemophilia, primary immunodeficiency, autoimmune disorders, and other rare diseases. Service lines include Paragon Infusion Centers, Paragon Home Infusion, Paragon Hemophilia, Paragon Specialty Pharmacy, and IVIG therapy, all supported by insurance verification, prior authorization, 24/7 pharmacist support, and coordination with referring physicians.
Is Paragon Healthcare a public or private company?
Paragon Healthcare is a private company. It is classified as corporate owned and is currently operating.
When was Paragon Healthcare founded?
Paragon Healthcare was founded in 2002. It employs 1,001 to 5,000 people.
Where is Paragon Healthcare based?
Paragon Healthcare is headquartered in Dallas, United States, in the North America region.
How does Paragon Healthcare make money?
One revenue line is on record: specialty Pharmacy and Infusion Services.
Who are Paragon Healthcare's main competitors?
Direct peers on record are Option Care Health, Pentec Health, Soleo Health, BioMatrix Specialty Pharmacy, IVX Health, Vivo Infusion and Amerita. Broad incumbents are Accredo (Express Scripts / Evernorth), Coram CVS Health (Coram) and Walgreens Specialty Pharmacy (including Option Care legacy).
Does Paragon Healthcare have an API?
No public API is recorded for Paragon Healthcare.
What industry is Paragon Healthcare in?
Paragon Healthcare's product category is Specialty Infusion Therapy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFAEAE, Home Infusion Therapy Providers. Its NAICS code is 621498 and its SIC code is 8093.